<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25464381</article-id><article-id pub-id-type="pmc">4284686</article-id><article-id pub-id-type="doi">10.3390/ijms151221935</article-id><article-id pub-id-type="publisher-id">ijms-15-21935</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Role of <italic>Aeromonas hydrophila</italic> Flagella Glycosylation in Adhesion to Hep-2 Cells, Biofilm Formation and Immune Stimulation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Merino</surname><given-names>Susana</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wilhelms</surname><given-names>Markus</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tom&#x000e1;s</surname><given-names>Juan M.</given-names></name><xref rid="c1-ijms-15-21935" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-ijms-15-21935">Departamento de Microbiolog&#x000ed;a, Facultad de Biolog&#x000ed;a, Universidad de Barcelona, Diagonal 643, 08071 Barcelona, Spain; E-Mails: <email>smerino@ub.edu</email> (S.M.); <email>mwilhelms@ub.edu</email> (M.W.)</aff><author-notes><corresp id="c1-ijms-15-21935"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>jtomas@ub.edu</email>; Tel.: +34-93-4021-486; Fax: +34-93-4039-047.</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2014</year></pub-date><volume>15</volume><issue>12</issue><fpage>21935</fpage><lpage>21946</lpage><history><date date-type="received"><day>04</day><month>9</month><year>2014</year></date><date date-type="rev-recd"><day>13</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2014</copyright-year><license><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Abstract:</bold> Polar flagellin proteins from <italic>Aeromonas hydrophila</italic> strain AH-3 (serotype O34) were found to be <italic>O</italic>-glycosylated with a heterogeneous heptasaccharide glycan. Two mutants with altered (light and strong) polar flagella glycosylation still able to produce flagella were previously obtained, as well as mutants lacking the O34-antigen lipopolysaccharide (LPS) but with unaltered polar flagella glycosylation. We compared these mutants, altogether with the wild type strain, in different studies to conclude that polar flagella glycosylation is extremely important for <italic>A. hydrophila</italic> adhesion to Hep-2 cells and biofilm formation. Furthermore, the polar flagella glycosylation is an important factor for the immune stimulation of IL-8 production via toll receptor 5 (TLR5).</p></abstract><kwd-group><kwd><italic>O</italic>-flagellin glycosylation</kwd><kwd>adhesion</kwd><kwd>biofilm</kwd><kwd>immune stimulation</kwd></kwd-group></article-meta></front><body><sec><title>1. Introduction</title><p>The mesophilic <italic>Aeromonas</italic>
<italic>hydrophila</italic> motility is based on a single polar flagellum expressed constitutively. The flagella morphogenesis in <italic>A. hydrophila</italic>, as in other Gram-negative bacteria, is a complex phenomenon that requires coordinated expression of more than 50 genes encoding structural subunits, regulatory proteins and chemo-sensor machinery. The motility by flagella represents an important advantage in moving towards favorable conditions or in avoiding detrimental environments [<xref rid="B1-ijms-15-21935" ref-type="bibr">1</xref>], and it allows in this case mesophilic <italic>Aeromonas</italic> to compete with other microorganisms. These bacteria are ubiquitous water-borne bacteria, considered opportunistic pathogens of both aquatic and terrestrial animals, some species being associated with gastrointestinal and extraintestinal human diseases [<xref rid="B2-ijms-15-21935" ref-type="bibr">2</xref>].</p><p>Some of the <italic>A. hydrophila</italic> strains (about 60%) are able to induce new flagella (named lateral) when grown in solid or semisolid surfaces [<xref rid="B3-ijms-15-21935" ref-type="bibr">3</xref>]. The morphogenesis of the <italic>A. hydrophila</italic> lateral flagella also involves more than 35 different genes encoding structural subunits, regulatory proteins and chemo-sensor machinery [<xref rid="B4-ijms-15-21935" ref-type="bibr">4</xref>]. Both, the polar and the lateral flagella in these strains are involved in adherence to biotic or abiotic surfaces and to biofilm formation as has been previous documented [<xref rid="B5-ijms-15-21935" ref-type="bibr">5</xref>]. Glycosylation, either <italic>N</italic> or <italic>O</italic> linked, is increasingly being observed in bacteria (reviewed in [<xref rid="B6-ijms-15-21935" ref-type="bibr">6</xref>,<xref rid="B7-ijms-15-21935" ref-type="bibr">7</xref>,<xref rid="B8-ijms-15-21935" ref-type="bibr">8</xref>]), with the most commonly reported bacterial glycoproteins being flagellins and pili. Frequently, the linkage of the glycan to the proteins is an <italic>O</italic>-linkage of the sugar moiety to the hydroxyl oxygen of serine (Ser) or threonine (Thr) residues [<xref rid="B6-ijms-15-21935" ref-type="bibr">6</xref>]. We recently demonstrated that polar and lateral flagellin proteins from <italic>A. hydrophila</italic> strain AH-3 (serotype O34) are glycosylated with different carbohydrate moieties [<xref rid="B9-ijms-15-21935" ref-type="bibr">9</xref>]. The lateral flagellin is modified at three sites in <italic>O</italic>-linkage, with a single monosaccharide shown to be a pseudaminic acid derivative of 376 Da. The polar flagellin is <italic>O</italic>-glycosylated by a heptasaccharide linked through a 376 Da pesudaminic acid type sugar. This glycan chain is composed by the mentioned 376 Da sugar, plus the hexasaccharide (2-Hexoses, 3-<italic>N</italic>-acetylhexosamines unsubstituted or substituted with phosphate and methylgroups, and an unknown moiety 102 Da) [<xref rid="B9-ijms-15-21935" ref-type="bibr">9</xref>]. The 376 Da sugar is a derivative of pseudaminic acid, and the mutants obtained in the pseudaminic acid biosynthetic pathway abolish the production of <italic>A. hydrophila</italic> polar and lateral flagella [<xref rid="B9-ijms-15-21935" ref-type="bibr">9</xref>]. The heptasaccharide polar flagellin glycan is different from the <italic>A. hydrophila</italic> O34 antigen lipopolysaccharide (LPS) [<xref rid="B10-ijms-15-21935" ref-type="bibr">10</xref>]. Additionally, this polar flagellin glycan is biosynthesized through an enzyme (WecX), which links the glycan to a lipid carrier independently of the O34 antigen biosynthesis [<xref rid="B11-ijms-15-21935" ref-type="bibr">11</xref>].</p><p>However, we previously reported two mutants with altered polar flagella glycosylation in different degrees, but still able to form flagella (<xref ref-type="fig" rid="ijms-15-21935-f001">Figure 1</xref>) [<xref rid="B11-ijms-15-21935" ref-type="bibr">11</xref>]. This fact allows us in this study to compare these mutants to the wild type strain, and then to determine the role of flagellin glycosylation in several pathogenic features like bacterial adhesion or biofilm formation, as well as in immune stimulation.</p><fig id="ijms-15-21935-f001" position="float"><label>Figure 1</label><caption><p>(<bold>A</bold>) Electron microscopy of whole cells from <italic>A. hydrophila</italic> strains stained according to <xref ref-type="sec" rid="sec4-ijms-15-21935">Experimental Section</xref>. Bar represents 1 &#x000b5;m; (<bold>B</bold>) SDS-PAGE of purified polar flagellins, Coomasie blue stained. St, size standard. 1, <italic>A. hydrophila</italic> AH-3 (wild type); 2, <italic>A. hydrophila</italic> AH-3&#x00394;WecP mutant; and 3, <italic>A. hydrophila</italic> AH-3:<italic>gne</italic> (AH-2767) mutant.</p></caption><graphic xlink:href="ijms-15-21935-g001"/></fig></sec><sec><title>2. Results</title><p>WecP is the enzyme that catalyzes the transfer of GalNAc-1-phosphate onto lipid carrier (undecaprenyl-phosphate) in the biosynthesis of the <italic>A. hydrophila</italic> AH-3 O34-antigen LPS [<xref rid="B12-ijms-15-21935" ref-type="bibr">12</xref>]. The AH-3&#x00394;WecP mutant, therefore, lacks the O34-antigen LPS [<xref rid="B12-ijms-15-21935" ref-type="bibr">12</xref>]. Mutant AH-3&#x00394;WecP is still able to produce polar flagella besides being impaired in their flagella glycosylation [<xref rid="B11-ijms-15-21935" ref-type="bibr">11</xref>]. Mutant AH-3&#x00394;WecP showed the same heptasaccharide chains of the wild type strain for polar flagella glycosylation but a much lower intensity. It means that several glycopeptides are not fully glycosylated in the mutant with clearly reduced amounts of phosphorylation or methylation of the sugars [<xref rid="B11-ijms-15-21935" ref-type="bibr">11</xref>]. We consider this mutant as the one with a light reduction in polar flagella glycosylation and motility.</p><p>Gne is the enzyme able to 4-epimerize UDP-GlcNAc to UDP-GalNAc, then the mutant lacking Gne (AH-2767) should be unable to produce UDP-GalNAc [<xref rid="B13-ijms-15-21935" ref-type="bibr">13</xref>]. Mutant AH-2767 is still able to produce polar flagella but showed a drastic reduction in glycosylation as their polar flagellin is only glycosylated by Pse or truncated glycan chains with Pse together with one or two hexoses as major moieties [<xref rid="B11-ijms-15-21935" ref-type="bibr">11</xref>]. As we previously indicated, the HexNAc residues for polar flagella glycosylation of wild type strain AH-3 could be GalNAc. We consider this mutant as one with a strong reduction in polar flagella glycosylation and motility. This mutant lacks the O34-antigen LPS because GalNAc is a component of it [<xref rid="B13-ijms-15-21935" ref-type="bibr">13</xref>].</p><p>A schematic representation for the polar flagellin glycosylation of these two mutants compared to the wild type one is shown in <xref ref-type="fig" rid="ijms-15-21935-f002">Figure 2</xref>.</p><fig id="ijms-15-21935-f002" position="float"><label>Figure 2</label><caption><p>Schematic representation for the polar flagellin glycosylation of the wild type, and mutants AH-3&#x00394;WecP and AH-2767:<italic>gne</italic>.</p></caption><graphic xlink:href="ijms-15-21935-g002"/></fig><sec><title>2.1. Adhesion to HEp-2 Cells and Biofilm Formation</title><p>In order to correlate polar flagella and their glycosylation, O34-antigen LPS, and motility with adherence to mammalian cells, we examined the interaction of several polar flagella and O34-antigen LPS mutants with cultured monolayers of HEp-2 cells. WecX is an enzyme able to link sugars to a lipid carrier responsible for the heptasaccharide glycosylation of the polar flagellin. Mutants lacking WecX are unable to produce flagella but showed no alterations in O34-antigen LPS [<xref rid="B11-ijms-15-21935" ref-type="bibr">11</xref>]. ManC is the enzyme responsible for the isomerization of mannose-6-P to mannose-1-P guanylyl transferase. Because mannose is a component of O34-antigen LPS, the mutant (&#x00394;ManC) lacks O-antigen LPS [<xref rid="B11-ijms-15-21935" ref-type="bibr">11</xref>,<xref rid="B14-ijms-15-21935" ref-type="bibr">14</xref>]. Differences in adherence were calculated by determining the average number of bacteria adhering to HEp-2 cells (<xref ref-type="table" rid="ijms-15-21935-t001">Table 1</xref>).</p><table-wrap id="ijms-15-21935-t001" position="float"><object-id pub-id-type="pii">ijms-15-21935-t001_Table 1</object-id><label>Table 1</label><caption><p>Adhesion of different <italic>A. hydrophila</italic> serotype O34 strains to HEp-2 cells as described in <xref ref-type="sec" rid="sec4-ijms-15-21935">Experimental section</xref>. Values presented are mean +/&#x02212; SD from three independent experiments carried out in duplicates or triplicates (<italic>n</italic> = 6 or <italic>n</italic> = 9).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Strain and Characteristics</th><th align="center" valign="middle" rowspan="1" colspan="1">Mean No. of Bacteria/ HEp-2 Cell +/&#x02212; SD</th><th align="center" valign="middle" rowspan="1" colspan="1">% Reduction in Adhesion <sup>a</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3 (wild type)</td><td align="center" valign="middle" rowspan="1" colspan="1">18.3 +/&#x02212; 2.2</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-2767:
<italic>gne</italic> mutant (O34<sup>&#x02212;</sup>; flagella<sup>&#x02212;&#x02212;</sup><sup>/+</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.2 +/&#x02212; 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">61 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-2767 + pACYC-GNE</td><td align="center" valign="middle" rowspan="1" colspan="1">18.0 +/&#x02212; 2.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;WecP (WecP mutant) (O34<sup>&#x02212;</sup>; flagella<sup>&#x02212;/+</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.8 +/&#x02212; 1.0</td><td align="center" valign="middle" rowspan="1" colspan="1">46</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;WecP + pBAD-WecP</td><td align="center" valign="middle" rowspan="1" colspan="1">17.9 +/&#x02212; 1.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;ManC (O34<sup>&#x02212;</sup> mutant)&#x02192;(O34<sup>&#x02212;</sup>; flagella<sup>+</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.2 +/&#x02212; 1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">23</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;ManC + pBAD-ManC</td><td align="center" valign="middle" rowspan="1" colspan="1">18.7 +/&#x02212; 1.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;PseB (flagella<sup>&#x02212;</sup>) (O34<sup>+</sup>; flagella<sup>&#x02212;</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.2 +/&#x02212; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1">88</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;PseB + pBAD-PseB</td><td align="center" valign="middle" rowspan="1" colspan="1">17.6 +/&#x02212; 2.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;PseB&#x00394;ManC (flagella<sup>&#x02212;</sup>, O34<sup>&#x02212;</sup> mutant)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;90</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3:WecX (flagella<sup>&#x02212;</sup>, O34<sup>+</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.3 +/&#x02212; 0.4</td><td align="center" valign="middle" rowspan="1" colspan="1">87</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3:WecX + pBAD-WecX</td><td align="center" valign="middle" rowspan="1" colspan="1">18.1 +/&#x02212; 1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;5</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> The level of adhesion of strain AH-3 was used as 100% value; <sup>b</sup> Student&#x02019;s <italic>t</italic> test, <italic>p</italic>, 0.001; <sup>&#x02212;</sup>, lack of the corresponding structure; <sup>+</sup>, presence of the corresponding structure; &#x02212;/+, light reduction of polar flagella glycosylation; <sup>&#x02212;/&#x02212;+</sup>, strong reduction of polar flagella glycosylation. </p></fn></table-wrap-foot></table-wrap><p>The <italic>A. hydrophila</italic> wild type strain, AH-3, exhibited an adhesion value of 18.3 (18.3 &#x000b1; 2.2) bacteria adhered per HEp-2 cell and a biofilm formation ability with an OD<sub>570</sub> value of 1.32 (1.32 &#x000b1; 0.11). Mutants lacking both flagella (polar and lateral) and O34-antigen LPS (AH-3&#x00394;PseB&#x00394;ManC) showed no adhesion to eukaryotic cells, while mutants lacking only flagella (AH-3&#x00394;PseB or AH-3:WecX) showed a minimal adhesion value with a drastic reduction compared with the wild type. When a mutant lacking only O34-antigen LPS with unaltered flagella (AH-3&#x00394;ManC) was examined only a moderate reduction (23%) in Hep-2 cell adhesion was observed. Mutants AH-3&#x00394;WecP and AH-2767 are devoid of O34-antigen LPS [<xref rid="B12-ijms-15-21935" ref-type="bibr">12</xref>,<xref rid="B13-ijms-15-21935" ref-type="bibr">13</xref>], but AH-2767 mutant showed a greater reduction in Hep-2 cell adhesion than AH-3&#x00394;WecP, probably because their flagella glycosylation is more severely affected.</p><p>We also compared the ability of the wild type and the different mutant strains to form biofilms in microtiter plates (<xref ref-type="table" rid="ijms-15-21935-t002">Table 2</xref>).</p><table-wrap id="ijms-15-21935-t002" position="float"><object-id pub-id-type="pii">ijms-15-21935-t002_Table 2</object-id><label>Table 2</label><caption><p>Biofilm values of several <italic>A. hydrophila</italic> strains using the method of Pratt and Kolter as indicated in the <xref ref-type="sec" rid="sec4-ijms-15-21935">Experimental Section</xref>. Values presented are mean +/&#x02212; SD from three independent experiments carried out in triplicates (<italic>n</italic> = 9).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Strain and Characteristics</th><th align="center" valign="middle" rowspan="1" colspan="1">Value (OD<sub>570</sub>)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3 (wild type)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.32 +/&#x02212; 0.11</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-2767:
<italic>gne</italic> mutant (O34<sup>&#x02212;</sup>; flagella<sup>&#x02212;&#x02212;/+</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;WecP (O34<sup>&#x02212;</sup>; flagella<sup>&#x02212;/+</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.47 +/&#x02212; 0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;ManC (O34<sup>&#x02212;</sup>; flagella<sup>+</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.65 +/&#x02212; 0.07</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;PseB (flagella<sup>&#x02212;</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;PseB&#x00394;ManC (O34<sup>&#x02212;</sup>; flagella<sup>&#x02212;</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3:WecX (flagella<sup>&#x02212;</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-2767:
<italic>gne</italic> mutant + pACYC-GNE</td><td align="center" valign="middle" rowspan="1" colspan="1">1.30 +/&#x02212; 0.15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;WecP + pBAD-WecP</td><td align="center" valign="middle" rowspan="1" colspan="1">1.29 +/&#x02212; 0.13</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;ManC + pBAD-ManC</td><td align="center" valign="middle" rowspan="1" colspan="1">1.31 +/&#x02212; 0.10</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;PseB + pBAD-PseB</td><td align="center" valign="middle" rowspan="1" colspan="1">1.27 +/&#x02212; 0.12</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3:WecX + pBAD-WecX</td><td align="center" valign="middle" rowspan="1" colspan="1">1.29 +/&#x02212; 0.08</td></tr></tbody></table><table-wrap-foot><fn><p><sup>&#x02212;</sup> lack of the corresponding structure; <sup>+</sup>, presence of the corresponding structure; &#x02212;/+, light reduction of polar flagella glycosylation; <sup>&#x02212;/&#x02212;+</sup>, strong reduction of polar flagella glycosylation.
</p></fn></table-wrap-foot></table-wrap><p>The results obtained for biofilm formation show a similar overall pattern to the adhesion, when comparing the characteristics of wild type and mutant strains. However, the effects are more drastic when observing reduction in biofilm formation. Mutants lacking flagella (AH-3&#x00394;PseB and AH-3:WecX) or flagella and O34-antigen LPS altogether (AH-3&#x00394;pseB&#x00394;ManC) are unable to form biofilms, with values &#x0003c;0.2, which is the limit of detection for the assay (<xref ref-type="table" rid="ijms-15-21935-t002">Table 2</xref>). In the AH-3&#x00394;ManC mutant, the lack of O34-antigen LPS alone, reduced, by approximately 50%, the ability to produce biofilms (observed value of 0.65 compared with 1.32 for wild type). AH-3&#x00394;WecP and AH-2767 mutants showed a highly reduced ability to form biofilms in comparison with the AH-3&#x00394;ManC mutant, and again the reduction is less drastic in mutant AH-3&#x00394;WecP (value of 0.47) than in AH-2767 (&#x0003e;0.2). In all cases, adhesion to Hep2-cells and biofilm formation of the mutants were fully rescued by the introduction of the wild type genes (<xref ref-type="table" rid="ijms-15-21935-t001">Table 1</xref> and <xref ref-type="table" rid="ijms-15-21935-t002">Table 2</xref>). No differences were observed when mutant strains harbor the plasmid vector alone.</p></sec><sec><title>2.2. IL-8 Immune Stimulation</title><p>The HEK293 cell line was stably transfected with toll receptor 5 (TLR5) and the production of IL-8 used to assess the degree of TLR5 activation. Control HEK293-null cells stimulated with two concentrations of purified <italic>A. hydrophila</italic> AH-3 polar flagellins showed no IL-8 production. HEK293-hTLR5 cells stimulated with purified polar flagellins from wild type and both mutants (AH-3&#x00394;WecP and AH-2767) showed varying levels of IL-8 production (<xref ref-type="fig" rid="ijms-15-21935-f003">Figure 3</xref>). Polar flagellins from AH-3&#x00394;ManC mutant lacking O34-antigen LPS are fully glycosylated, with sugars phosphorylated and methylated, showing similar values as the wild type.</p><p>The highest levels of IL-8 production were observed when cells were stimulated with wild type polar flagellin. Stimulation of cells with polar flagellin from the <italic>gne</italic> mutant (AH-2767) resulted in over a 70% reduction in IL-8 production relative to wild type polar flagellin. This was observed when cells were stimulated with 12.5, 25 or 50 ng of flagellin. When cells were stimulated with polar flagellin from the AH-3&#x00394;WecP mutant, a 50% reduction in IL-8 production was observed compared to wild type one. In each case, the amount of IL-8 produced was dose dependent increasing with the flagellin concentration added. A full recovery of polar flagellin stimulated IL-8 production was observed when AH-3&#x00394;WecP and AH-2767 mutants were rescued with the single <italic>gne</italic> or <italic>wecP</italic>, respectively (<xref ref-type="fig" rid="ijms-15-21935-f003">Figure 3</xref>).</p><p>No IL-8 production was obtained by HEK293-hTLR5 cells when stimulated with higher concentrations (up to 100 ng) of the nonglycosylated AH-3 polar flagellins His<sub>6</sub>-FlaA and His<sub>6</sub>-FlaB proteins obtained in <italic>E. coli</italic> (see <xref ref-type="sec" rid="sec4-ijms-15-21935">Experimental Section</xref>).</p><fig id="ijms-15-21935-f003" position="float"><label>Figure 3</label><caption><p>Human embryonic kidney cells (HEK293-null) and cells stably transfected with the human toll receptor 5 (TLR5)-gene (<italic>HEK293-hTLR5</italic>) were exposed to three different amounts of purified <italic>A. hydrophila</italic> AH-3 wild type or both mutants (AH-3&#x00394;WecP and AH-2767) polar flagellins and IL-8 release was measured. The data represent the mean +/&#x02212; SD of three independent experiments carried out in triplicates (<italic>n</italic> = 9). * <italic>p</italic> &#x0003c; 0.05, student&#x02019;s <italic>t</italic>-test compared to the AH-3.</p></caption><graphic xlink:href="ijms-15-21935-g003"/></fig></sec></sec><sec><title>3. Discussion</title><p>Mutants AH-3&#x00394;WecP and AH-2767:<italic>gne</italic> lack the O34-antigen LPS, and our previous adhesion and biofilm studies indicate that the O34-antigen LPS is a factor for bacterial adhesion and biofilm production [<xref rid="B13-ijms-15-21935" ref-type="bibr">13</xref>]. However, bacterial adhesions to eukaryotic cells or biofilm production are pathogenic features depending on multifactorial components [<xref rid="B15-ijms-15-21935" ref-type="bibr">15</xref>,<xref rid="B16-ijms-15-21935" ref-type="bibr">16</xref>].</p><p>Our current work suggests that the flagellum is a major adhesin and that motility is an important factor for adhesion. The flagella glycosylation is determinant for adhesion to eukaryotic cells or biofilm formation, as described in other mucosal pathogens [<xref rid="B17-ijms-15-21935" ref-type="bibr">17</xref>,<xref rid="B18-ijms-15-21935" ref-type="bibr">18</xref>,<xref rid="B19-ijms-15-21935" ref-type="bibr">19</xref>]. The comparison between mutants only devoid of O34-antigen LPS but with complete flagella, and flagella glycosylation AH-2767 <italic>gne</italic> and AH-3&#x00394;WecP mutants with altered flagella glycosylation, allows us to conclude that a full, functional polar flagellum for bacterial adhesion is only achieved when the flagella glycosylation is complete (full heptasaccharide with phosphate and methyl groups). Reduced polar flagella glycosylation is related to reduce adhesion to eukaryotic cells, being deeper in mutant with strong polar flagella glycosylation reduction (AH-2767:<italic>gne</italic>) than the one with light reduction (AH-3&#x00394;WecP).</p><p>A similar, but more drastic, situation is observed when we studied the ability to produce biofilms of mutants only devoid of O34-antigen LPS but with complete flagella and flagella glycosylation and AH-2767:<italic>gne</italic> and AH-3&#x00394;WecP mutants with altered flagella glycosylation. In this case the mutant with strong polar flagella glycosylation reduction (AH-2767:<italic>gne</italic>) is already unable to produce biofilms like mutants without flagella. The mutant with light polar flagella glycosylation reduction (AH-3&#x00394;WecP) is still able to produce biofilm but with a clear reduction compared to the one for mutants only devoid of O34-antigen LPS.</p><p>Toll-like receptors (TLRs) are one of the key components of innate immunity. Among various types of TLRs, TLR5 is involved in recognizing bacterial flagellin and, after binding, it triggers myeloid differentiation primary response gene 88 (MyD88)-dependent signaling pathway to induce pro-inflammatory cytokines like IL-8 [<xref rid="B20-ijms-15-21935" ref-type="bibr">20</xref>]. Our results indicate that <italic>A. hydrophila</italic> polar flagellin glycosylation is important for immure stimulation of IL-8 production via TLR5. Furthermore, the level of flagellin glycosylation directly correlates with the enhancement of IL-8 production. No IL-8 production in the assay described is observed when we used polar unglycosylated flagellin monomers (FlaA or FlaB) obtained in <italic>E. coli</italic>. It has been described that fish infected with pathogenic bacteria showed the majority of their tissues with significant enhanced expression of IL-8 for instance in the blood and intestine, and suggest the important role of TLR5 in augmenting innate immunity in fish in response to pathogenic invasion [<xref rid="B21-ijms-15-21935" ref-type="bibr">21</xref>]. Then, it is tempting to speculate, the possible role of <italic>A. hydrophila</italic> AH-3 polar flagella glycosylation in cell invasion as it is a characteristic observed for the wild-type strain [<xref rid="B22-ijms-15-21935" ref-type="bibr">22</xref>].</p><p>In conclusion, the current study starts to shed light on the biological role of flagella glycosylation not only in flagella formation and motility, either in adherence to Hep-2 cells or biofilm formation and TLR5 activation.</p></sec><sec id="sec4-ijms-15-21935"><title>4. Experimental Section</title><sec><title>4.1. Bacterial Strains, Plasmids and Growth Conditions</title><p>The bacterial strains and plasmids used in this study are listed in <xref ref-type="table" rid="ijms-15-21935-t003">Table 3</xref>. <italic>E. coli</italic> strains were grown on Luria&#x02013;Bertani (LB) Miller broth and LB Miller agar at 37 &#x000b0;C, while <italic>A. hydrophila</italic> strains were grown either in tryptic soy broth (TSB) or agar (TSA) at 30 &#x000b0;C. When indicated chloramphenicol (25 &#x000b5;g/mL), kanamycin (50 &#x000b5;g/mL), and tetracycline (20 &#x000b5;g/mL) were added to the media.</p><table-wrap id="ijms-15-21935-t003" position="float"><object-id pub-id-type="pii">ijms-15-21935-t003_Table 3</object-id><label>Table 3</label><caption><p>Bacterial strains and plasmids used.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Strain or Plasmid</th><th align="center" valign="middle" rowspan="1" colspan="1">Relevant Characteristics</th><th align="center" valign="middle" rowspan="1" colspan="1">Reference or Source</th></tr></thead><tbody><tr><td colspan="3" align="center" valign="middle" rowspan="1"><italic>E. coli</italic> strains</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1">DH5&#x003b1;</td><td align="center" valign="middle" rowspan="1" colspan="1">F<sup>&#x02212;</sup>
<italic>end A hsdR17</italic> (rK<sup>&#x02212;</sup> mK<sup>+</sup>) <italic>supE44 thi-1 recA1</italic>
<italic>gyr-A96 _80lacZ</italic>M15</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BL21(&#x003bb;D3)</td><td align="center" valign="middle" rowspan="1" colspan="1">F&#x02212; <italic>ompT hsdS<sub>B</sub></italic> (r<sub>B</sub><sup>&#x02212;</sup> m<sub>B</sub><sup>&#x02212;</sup>) <italic>gal dcm</italic>(&#x003bb;D3)</td><td align="center" valign="middle" rowspan="1" colspan="1">Novagen</td></tr><tr style="border-top: solid thin"><td colspan="3" align="center" valign="middle" rowspan="1"><italic>A. hydrophila</italic> strains</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1">AH-3</td><td align="center" valign="middle" rowspan="1" colspan="1">O34, Wild type</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">12</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-2767</td><td align="center" valign="middle" rowspan="1" colspan="1">AH-3:<italic>gne</italic> mutant Km<sup>R</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">13</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;WecP</td><td align="center" valign="middle" rowspan="1" colspan="1">AH-3 WecP mutant</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">12</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;ManC</td><td align="center" valign="middle" rowspan="1" colspan="1">AH-3 mutant in frame unable produce O34-antigen LPS</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">11</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;PseB</td><td align="center" valign="middle" rowspan="1" colspan="1">AH-3 <italic>pseB</italic> mutant in frame with pDM4</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3&#x00394;PseF&#x00394;ManC</td><td align="center" valign="middle" rowspan="1" colspan="1">AH-3 double mutant <italic>pseB</italic> and in frame unable produce O34-antigen LPS</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">11</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AH-3:WecX</td><td align="center" valign="middle" rowspan="1" colspan="1">AH-3 <italic>wecX</italic> defined insertion mutant, Cm<sup>R</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">11</xref>]</td></tr><tr style="border-top: solid thin"><td colspan="3" align="center" valign="middle" rowspan="1">Plasmids</td></tr><tr style="border-top: solid thin"><td align="center" valign="middle" rowspan="1" colspan="1">pET-30 Xa/LIC</td><td align="center" valign="middle" rowspan="1" colspan="1">IPTG inducible expression vector Km<sup>R</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">Novagen</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pET-30-FlaA</td><td align="center" valign="middle" rowspan="1" colspan="1">pET-30 Xa/LIC with <italic>A. hydrophila</italic> AH-3 <italic>flaA</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pET-30-FlaB</td><td align="center" valign="middle" rowspan="1" colspan="1">pET-30 Xa/LIC with <italic>A. hydrophila</italic> AH-3 <italic>flaB</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">This study</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pBAD-ManC</td><td align="center" valign="middle" rowspan="1" colspan="1">pBAD33 with AH-3 <italic>manC</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">11</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pBAD-WecP</td><td align="center" valign="middle" rowspan="1" colspan="1">pBAD33 with AH-3 <italic>wecP</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">12</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pBAD-WecX</td><td align="center" valign="middle" rowspan="1" colspan="1">pBAD33 with AH-3 <italic>wecX</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">11</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pACYC-GNE</td><td align="center" valign="middle" rowspan="1" colspan="1">pACYC184 with AH-3 <italic>gne</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B3-ijms-15-21935" ref-type="bibr">13</xref>]</td></tr></tbody></table></table-wrap></sec><sec><title>4.2. Motility Assays</title><p>Freshly grown bacterial colonies were transferred with a sterile toothpick into the centre of swim agar (1% tryptone, 0.5% NaCl, 0.25% agar). The plates were incubated face up for 16&#x02013;24 h at 25 &#x000b0;C and motility was assessed by examining the migration of bacteria through the agar from the center towards the periphery of the plate. Furthermore, motility was also assessed by light microscopy observations in liquid media.</p></sec><sec><title>4.3. Transmission Electron Microscopy (TEM)</title><p>Bacterial suspensions were placed on Formvar-coated grids and negative stained with a 2% solution of uranyl acetate pH 4.1. Preparations were observed on a Hitachi 600 transmission electron microscope.</p></sec><sec><title>4.4. Flagella Purification</title><p><italic>A. hydrophila</italic> AH-3 was grown in TSB for the polar flagellum purification. For the isolation of lateral flagella the strains were grown in TSA and plates washed with 100 mM Tris (pH = 7.8). Cells were in both cases collected by centrifugation at 5000&#x000d7; <italic>g</italic>, and suspended in the same Tris buffer. Flagella were removed from the cells by shearing in a vortex with a glass bar for 3&#x02013;4 min, and then passing repetitively (minimum six times) through a syringe. Cells were removed by centrifugation at 8000&#x000d7; <italic>g</italic> for 30 min, and the supernatant centrifuged at 18,000&#x000d7; <italic>g</italic> for 20 min. From the remaining supernatant the flagella were pelleted by ultracentrifugation at 100,000&#x000d7; <italic>g</italic> for 60 min, and resuspended in 100 mM Tris (pH = 7.8) plus 2 mM EDTA buffer. This flagella enriched fraction was purified in a cesium chloride gradient by ultracentifugation at 60,000&#x000d7; <italic>g</italic> for 48 h. The band containing the flagella was collected, the cesium chloride removed by extensive dialysis against the same buffer (100 mM Tris, 2 mM EDTA). Purified flagella were quantified by Bradford method to evaluate protein concentration, analyzed by SDS-PAGE and Coomasie blue stained.</p></sec><sec><title>4.5. Adherence Assay to HEp-2 Cell</title><p>The adherence assay was conducted as previously described by us [<xref rid="B24-ijms-15-21935" ref-type="bibr">24</xref>] with a slight modification of that described by Carrello <italic>et al.</italic> [<xref rid="B25-ijms-15-21935" ref-type="bibr">25</xref>]. Bacteria were grown statically in brain heart infusion broth (BHIB) at 37 &#x000b0;C, harvested by gentle centrifugation (1600&#x000d7; <italic>g</italic>, 5 min), and resuspended in PBS (pH 7.2) at approximately 10<sup>7</sup> CFU/mL <italic>(</italic>A<sub>600</sub> = 0.07). The HEp-2 cell monolayer was infected with 1 mL of the bacterial suspension for 90 min at 37 &#x000b0;C in 5% CO<sub>2</sub>. Following infection, the non-adherent bacteria were removed from the monolayer by three washes with PBS. The remaining adherent bacteria and the monolayers were then fixed in 100% methanol for 5 min. Methanol was removed by washing them with PBS, and the HEp-2 cells with the adherent bacteria were stained for 45 min in 10% (<italic>v</italic>/<italic>v</italic>) Giemsa stain (BDH) prepared in Giemsa buffer. The coverslips were air dried, mounted, and viewed by oil immersion under a light microscope. Twenty HEp-2 cells/coverslips were randomly chosen, and the number of bacteria adhering/HEp-2 cell was recorded. The number of bacteria per infected cell was expressed as the mean +/&#x02212; standard error of the mean, of a total of 75 cells for each assay. Assays were carried out in duplicates or triplicates.</p></sec><sec><title>4.6. Biofilm Formation</title><p>Quantitative biofilm formation was performed in a microtiter plate as described previously [<xref rid="B24-ijms-15-21935" ref-type="bibr">24</xref>], by adapting the method of Pratt and Kotler [<xref rid="B26-ijms-15-21935" ref-type="bibr">26</xref>] with minor modifications. Briefly, bacteria were grown on TSA and several colonies were gently resuspended in TSB (with or without the appropriated antibiotic); 100 &#x000b5;L aliquots were place in a microtiter plate (polystyrene) and incubated 48 h at 30 &#x000b0;C without shaking. After the bacterial cultures were poured out, the plate was washed extensively with water, fixed with 2.5% glutaraldehyde, washed once with water and stained with 0.4% crystal violet solution. After solubilization of the crystal violet with ethanol-acetone (80/20, <italic>v</italic>/<italic>v</italic>) the absorbance was determined at 570 nm.</p></sec><sec><title>4.7. Non-Glycosylated A. hydrophila Flagellins</title><p>To obtain non-glycosylated <italic>A. hydrophila</italic> flagellins FlaA and B we over-expressed <italic>A. hydrophila</italic> AH-3 <italic>flaA</italic> and <italic>B</italic> in <italic>E. coli</italic> using pET-30 Xa/LIC vector (Novagen, Darmstad, Germany). The <italic>A. hydrophila</italic> AH-3 <italic>flaA</italic> was amplified from AH-3 genomic DNA using primers PETflaAfor 5'-GGTATTGAGGGTGCGATGGGTCTTTAT-3&#x0a78c; and PETflaArev 5'-AGAGGAGAGTTAGAGCCTTTGTTAGCCTTGCAGCAG-3', while the <italic>flaB</italic> with PETflaBfor 5'-GGTATTGAGGGTGCGATGGCCATGTACATCAACAC-3' and PETflaBrev 5'-AGAGGAGAGTTAGAGCCGTTAACCCAGCAGGGACAG-3', and the PCR products obtained ligated independently into pET-30 Xa/LIC (Novagen, Darmstadt, Germany), and electroporated into <italic>E. coli</italic> BL21(<italic>&#x003bb;</italic>DE3). The His<sub>6</sub>-FlaA and His6-FlaB protein were overexpressed and cell lysates obtained as previously reported for other proteins [<xref rid="B27-ijms-15-21935" ref-type="bibr">27</xref>,<xref rid="B28-ijms-15-21935" ref-type="bibr">28</xref>]. The total membrane fraction was obtained by ultracentrifugation (200,000&#x000d7; <italic>g</italic> 30 min at 10 &#x000b0;C), the His<sub>6</sub>-FlaA and His<sub>6</sub>-FlaB proteins were solubilized and independently purified with a Ni<sup>2+</sup>-NTA agarose (Quiagen, Barcelona, Spain) as previously reported [<xref rid="B29-ijms-15-21935" ref-type="bibr">29</xref>]. When needed the His<sub>6</sub>-FlaA and His<sub>6</sub>-FlaB proteins were concentrated using a Centriplus 10-mL YM-30 centrifugal filter device (Amicon Bioseparations, Darmstad, Germany), and typical protein preparations contained yields of 0.07-0.08 g/mL as determined by the Bio-Rad Bradford assay (Barcelona, Spain).</p></sec><sec><title>4.8. Interleukin-8 (IL-8) Assay</title><p>Human embryonic kidney cells that were stably transfected with a plasmid carrying the human TLR5-gene (<italic>HEK293-hTLR5</italic>) and the corresponding control cell line that only expresses endogenous levels of TLR5 (HEK293-null) were obtained from InvivoGen (San Diego, CA, USA). The cells were maintained in Dulbecco&#x02019;s modified Eagle&#x02019;s medium supplemented with 14.5 g/L glucose, 10% (<italic>v</italic>/<italic>v</italic>) fetal bovine serum, 50 U/mL penicillin; 50 &#x000b5;g/mL streptomycin, 100 &#x000b5;g/mL Normocin, 2 mM <sc>l</sc>-glutamine in 75 cm<sup>3</sup> flasks and, without the supplementation of antibiotics, in 96-well plates for measurement of interleukin-8 (IL-8).</p><p>HEK293-hTLR5 and HEK293-null cells were seeded in 96-well plates and grown to confluence before stimulation with wild type and mutants purified flagella as indicated previously at different concentrations for 5 h. IL-8 concentration in the culture medium was determined using an enzyme-linked immunosorbent assay kit (Amersham Interleukin-8 ((h) IL-8) Human, Biotrak Elisa System; G.E. Healthcare, Buckinghamshire, UK) according to the instructions provided by the manufacturer.</p></sec><sec><title>4.9. Statistical Analysis</title><p>Results are expressed as the means standard deviations (SD) of three to four experiments. Student&#x02019;s <italic>t</italic><italic>-</italic>test was used to compare mean values. Differences were considered significant when <italic>p</italic> values were &#x0003c; 0.05.</p></sec></sec><sec><title>5. Conclusions</title><p>The current study starts to shed light on the biological role of flagella glycosylation not only in flagella formation and motility, either in adherence to Hep-2 cells or biofilm formation and TLR5 activation. The importance of flagella glycosylation in flagella production or motility in terms of qualitative &#x0201c;on-off&#x0201d; has been described. This study also demonstrated the importance of complete flagella glycosylation <italic>versus</italic> uncompleted flagella glycosylation (quantitative) in biological activities, such as adherence to Hep-2 cells or biofilm formation. A full flagella glycosylation is necessary for maximum adherence to Hep-2 cells or biofilm formation because intermediate levels of flagella glycosylation jeopardize both biological activities. Finally, the degree of IL-8 production via TLR5 activation by purified flagellin is directly linked to the flagella glycosylation amount. A non-full flagella glycosylation reduces the IL-8 production by TLR5 activation.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by Plan Nacional de I + D + i (Ministerio de Econom&#x000ed;a y Competitividad and Ministerio de Sanidad, Spain) and from Generalitat de Catalunya (Centre de Refer&#x000e8;ncia en Biotecnologia). We thank Maite Polo for her technical assistance and the Servicios Cient&#x000ed;fico-T&#x000e9;cnicos from the University of Barcelona.</p></ack><notes><title>Author Contributions</title><p>All the authors contributed to conceive and design experiments, as well as performed the experiments and analyzed the data. Susana Merino and Juan M. Tom&#x000e1;s wrote the paper.</p></notes><notes><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-15-21935"><label>1.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frenchel</surname><given-names>T.</given-names></name></person-group>
<article-title>Microbial behavior in a heterogeneous world</article-title>
<source>Science</source>
<year>2002</year>
<volume>296</volume>
<fpage>1068</fpage>
<lpage>1071</lpage>
<pub-id pub-id-type="pmid">12004118</pub-id></element-citation></ref><ref id="B2-ijms-15-21935"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Janda</surname><given-names>J.M.</given-names></name><name><surname>Abbott</surname><given-names>S.L.</given-names></name></person-group>
<article-title>The genus <italic>Aeromonas</italic>: Taxonomy, pathogenicity, and infection</article-title>
<source>Clin. Microbiol. Rev.</source>
<year>2010</year>
<volume>23</volume>
<fpage>35</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="pmid">20065325</pub-id></element-citation></ref><ref id="B3-ijms-15-21935"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimada</surname><given-names>T.</given-names></name><name><surname>Sakazaki</surname><given-names>R.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name></person-group>
<article-title>Peritrichous flagella in mesophilic strains of <italic>Aeromonas</italic></article-title>
<source>Jpn. J. Med. Sci. Biol.</source>
<year>1985</year>
<volume>38</volume>
<fpage>141</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="pmid">4068347</pub-id></element-citation></ref><ref id="B4-ijms-15-21935"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canals</surname><given-names>R.</given-names></name><name><surname>Altarriba</surname><given-names>M.</given-names></name><name><surname>Vilches</surname><given-names>S.</given-names></name><name><surname>Horsburg</surname><given-names>G.</given-names></name><name><surname>Shaw</surname><given-names>J.S.</given-names></name><name><surname>Tomas</surname><given-names>J.M.</given-names></name><name><surname>Merino</surname><given-names>S.</given-names></name></person-group>
<article-title>Analysis of the lateral flagella gene system of <italic>Aeromonas hydrophila</italic> AH-3</article-title>
<source>J. Bacteriol.</source>
<year>2006</year>
<volume>188</volume>
<fpage>852</fpage>
<lpage>862</lpage>
<pub-id pub-id-type="pmid">16428388</pub-id></element-citation></ref><ref id="B5-ijms-15-21935"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kirov</surname><given-names>S.M.</given-names></name><name><surname>Castrisios</surname><given-names>M.</given-names></name><name><surname>Shaw</surname><given-names>J.G.</given-names></name></person-group>
<article-title><italic>Aeromonas.</italic> flagella (polar and lateral) are enterocyte adhesins that contribute to biofilm formation on surfaces</article-title>
<source>Infect. Immun.</source>
<year>2004</year>
<volume>72</volume>
<fpage>1939</fpage>
<lpage>1945</lpage>
<pub-id pub-id-type="pmid">15039313</pub-id></element-citation></ref><ref id="B6-ijms-15-21935"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Logan</surname><given-names>S.M.</given-names></name></person-group>
<article-title>Flagellar glycosylation&#x02014;A new component of the motility repertoire?</article-title>
<source>Microbiology.</source>
<year>2006</year>
<volume>152</volume>
<fpage>1249</fpage>
<lpage>1262</lpage>
<pub-id pub-id-type="pmid">16622043</pub-id></element-citation></ref><ref id="B7-ijms-15-21935"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nothaft</surname><given-names>H.</given-names></name><name><surname>Symanski</surname><given-names>C.M.</given-names></name></person-group>
<article-title>Protein glycosylation in bacteria: Sweeter than ever</article-title>
<source>Nat. Rev. Microbiol.</source>
<year>2010</year>
<volume>8</volume>
<fpage>765</fpage>
<lpage>778</lpage>
<pub-id pub-id-type="pmid">20948550</pub-id></element-citation></ref><ref id="B8-ijms-15-21935"><label>8.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Twine</surname><given-names>S.M.</given-names></name><name><surname>Logan</surname><given-names>S.M.</given-names></name></person-group>
<article-title>Bacterial glycomic: Current research technology and applications</article-title>
<source>Current Research Technology and Applications</source>
<person-group person-group-type="editor"><name><surname>Reid</surname><given-names>S.W.</given-names></name><name><surname>Reid</surname><given-names>A.N.</given-names></name><name><surname>Twine</surname><given-names>S.M.</given-names></name></person-group>
<publisher-name>Caister Academic Press</publisher-name>
<publisher-loc>Norwich, UK</publisher-loc>
<year>2011</year>
</element-citation></ref><ref id="B9-ijms-15-21935"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wilhelms</surname><given-names>M.</given-names></name><name><surname>Fulton</surname><given-names>K.M.</given-names></name><name><surname>Twine</surname><given-names>S.M.</given-names></name><name><surname>Tom&#x000e1;s</surname><given-names>J.M.</given-names></name><name><surname>Merino</surname><given-names>S.</given-names></name></person-group>
<article-title>Differential glycosylation of polar and lateral flagellins in <italic>Aeromonas hydrophila</italic> AH-3</article-title>
<source>J. Biol. Chem.</source>
<year>2012</year>
<volume>287</volume>
<fpage>27851</fpage>
<lpage>27862</lpage>
<pub-id pub-id-type="pmid">22733809</pub-id></element-citation></ref><ref id="B10-ijms-15-21935"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Valvano</surname><given-names>M.A.</given-names></name></person-group>
<article-title>Common themes in glyconjugate assembly. Using the biogenesis of <italic>O</italic>-antigen lipopolysaccharide as a model system</article-title>
<source>Biochemistry</source>
<year>2011</year>
<volume>76</volume>
<fpage>729</fpage>
<lpage>735</lpage>
<pub-id pub-id-type="pmid">21999533</pub-id></element-citation></ref><ref id="B11-ijms-15-21935"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Merino</surname><given-names>S.</given-names></name><name><surname>Fulton</surname><given-names>K.M.</given-names></name><name><surname>Twine</surname><given-names>S.M.</given-names></name><name><surname>Wilhelms</surname><given-names>M.</given-names></name><name><surname>Molero</surname><given-names>R.</given-names></name><name><surname>Tom&#x000e1;s</surname><given-names>J.M.</given-names></name></person-group>
<article-title><italic>Aeromonas hydrophila</italic> flagella glycosylation: Involvement of a lipid carrier</article-title>
<source>PLoS One</source>
<year>2014</year>
<volume>9</volume>
<fpage>e89630</fpage>
<pub-id pub-id-type="pmid">24586923</pub-id></element-citation></ref><ref id="B12-ijms-15-21935"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Merino</surname><given-names>S.</given-names></name><name><surname>Jimenez</surname><given-names>N.</given-names></name><name><surname>Molero</surname><given-names>R.</given-names></name><name><surname>Bouamama</surname><given-names>L.</given-names></name><name><surname>Regu&#x000e9;</surname><given-names>M.</given-names></name><name><surname>Tom&#x000e1;s</surname><given-names>J.M.</given-names></name></person-group>
<article-title>A UDP-HexNAc: Polyprenol-P GalNAc-1-P transferase (WecP) representing a new subgroup of this enzyme family</article-title>
<source>J. Bacteriol.</source>
<year>2011</year>
<volume>193</volume>
<fpage>1943</fpage>
<lpage>1952</lpage>
<pub-id pub-id-type="pmid">21335454</pub-id></element-citation></ref><ref id="B13-ijms-15-21935"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canals</surname><given-names>R.</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>N.</given-names></name><name><surname>Vilches</surname><given-names>S.</given-names></name><name><surname>Regu&#x000e9;</surname><given-names>M.</given-names></name><name><surname>Merino</surname><given-names>S.</given-names></name><name><surname>Tom&#x000e1;s</surname><given-names>J.M.</given-names></name></person-group>
<article-title>The UDP <italic>N</italic>-acetylgalactosamine 4-epimerase gene is essential for mesophilic <italic>Aeromonas</italic> serotype O34 virulence</article-title>
<source>Infect. Immun.</source>
<year>2006</year>
<volume>74</volume>
<fpage>537</fpage>
<lpage>548</lpage>
<pub-id pub-id-type="pmid">16369010</pub-id></element-citation></ref><ref id="B14-ijms-15-21935"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knirel</surname><given-names>Y.A.</given-names></name><name><surname>Shaskov</surname><given-names>A.S.</given-names></name><name><surname>Sechenkova</surname><given-names>S.N.</given-names></name><name><surname>Merino</surname><given-names>S.</given-names></name><name><surname>Tom&#x000e1;s</surname><given-names>J.N.</given-names></name></person-group>
<article-title>Structure of the <italic>O</italic>-polysaccharide of <italic>Aeromonas hydrophila</italic> O34: A case of random <italic>O</italic>-acetylation of 6-deoxy-<sc>l</sc>-talose</article-title>
<source>Carbohydr. Res.</source>
<year>2002</year>
<volume>337</volume>
<fpage>1381</fpage>
<lpage>1386</lpage>
<pub-id pub-id-type="pmid">12204621</pub-id></element-citation></ref><ref id="B15-ijms-15-21935"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kleta</surname><given-names>S.</given-names></name><name><surname>Nordhoff</surname><given-names>M.</given-names></name><name><surname>Tedin</surname><given-names>K.</given-names></name><name><surname>Wieler</surname><given-names>L.H.</given-names></name><name><surname>Kolenda</surname><given-names>R.</given-names></name><name><surname>Oswald</surname><given-names>S.</given-names></name><name><surname>Oelschlaeger</surname><given-names>T.A.</given-names></name><name><surname>Blei&#x000df;</surname><given-names>W.</given-names></name><name><surname>Schierack</surname><given-names>P.</given-names></name></person-group>
<article-title>Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic <italic>Escherichia coli</italic> Nissle 1917 on atypical enteropathogenic <italic>E. coli</italic> infection</article-title>
<source>Infect. Immun.</source>
<year>2014</year>
<volume>82</volume>
<fpage>1801</fpage>
<lpage>1812</lpage>
<pub-id pub-id-type="pmid">24549324</pub-id></element-citation></ref><ref id="B16-ijms-15-21935"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stoodley</surname><given-names>P.</given-names></name><name><surname>Sauer</surname><given-names>K.</given-names></name><name><surname>Davies</surname><given-names>D.G.</given-names></name><name><surname>Costerton</surname><given-names>J.W.</given-names></name></person-group>
<article-title>Biofilms as complex differentiated communities</article-title>
<source>Annu. Rev. Microbiol.</source>
<year>2002</year>
<volume>56</volume>
<fpage>187</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="pmid">12142477</pub-id></element-citation></ref><ref id="B17-ijms-15-21935"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guerry</surname><given-names>P.</given-names></name></person-group>
<article-title><italic>Campylobacter</italic> flagella: Not just for motility</article-title>
<source>Trends Microbiol.</source>
<year>2007</year>
<volume>15</volume>
<fpage>456</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="pmid">17920274</pub-id></element-citation></ref><ref id="B18-ijms-15-21935"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Howard</surname><given-names>S.L.</given-names></name><name><surname>Jagannathan</surname><given-names>A.</given-names></name><name><surname>Soo</surname><given-names>E.C.</given-names></name><name><surname>Hui</surname><given-names>J.P.M.</given-names></name><name><surname>Aubry</surname><given-names>A.J.</given-names></name><name><surname>Ahmed</surname><given-names>I.</given-names></name><name><surname>Karlyshev</surname><given-names>A.</given-names></name><name><surname>Kelly</surname><given-names>J.F.</given-names></name><name><surname>Jones</surname><given-names>M.A.</given-names></name><name><surname>Stevens</surname><given-names>M.P.</given-names></name><etal/></person-group>
<article-title><italic>Campylobacter jejuni</italic> glycosylation island important in cell charge, legionaminic acid biosynthesis, and colonization of chickens</article-title>
<source>Infect. Immun.</source>
<year>2009</year>
<volume>77</volume>
<fpage>2544</fpage>
<lpage>2556</lpage>
<pub-id pub-id-type="pmid">19307210</pub-id></element-citation></ref><ref id="B19-ijms-15-21935"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asakura</surname><given-names>H.</given-names></name><name><surname>Churin</surname><given-names>Y.</given-names></name><name><surname>Bauer</surname><given-names>B.</given-names></name><name><surname>Boettcher</surname><given-names>J.P.</given-names></name><name><surname>Bartfeld</surname><given-names>S.</given-names></name><name><surname>Hashii</surname><given-names>N.</given-names></name><name><surname>Kawasaki</surname><given-names>N.</given-names></name><name><surname>Mollenkopf</surname><given-names>H.J.</given-names></name><name><surname>Jungblut</surname><given-names>P.R.</given-names></name><name><surname>Brinkmann</surname><given-names>V.</given-names></name><etal/></person-group>
<article-title><italic>Helicobacter pylori</italic> HP0518 affects flagellin glycosylation to alter bacterial motility</article-title>
<source>Mol. Microbiol.</source>
<year>2010</year>
<volume>78</volume>
<fpage>1130</fpage>
<lpage>1144</lpage>
<pub-id pub-id-type="pmid">21091500</pub-id></element-citation></ref><ref id="B20-ijms-15-21935"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>F.C.</given-names></name></person-group>
<article-title>Regulation of <italic>Salmonella</italic> flagellin-induced interleukin-8 in intestinal epithelial cells by muramyl dipeptide</article-title>
<source>Cell. Immunol.</source>
<year>2012</year>
<volume>278</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">23121969</pub-id></element-citation></ref><ref id="B21-ijms-15-21935"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basu</surname><given-names>M.</given-names></name><name><surname>Swain</surname><given-names>B.</given-names></name><name><surname>Maiti</surname><given-names>N.K.</given-names></name><name><surname>Routray</surname><given-names>P.</given-names></name><name><surname>Samanta</surname><given-names>M.</given-names></name></person-group>
<article-title>Inductive expression of toll-like receptor 5 (TLR5) and associated downstream signaling molecules following ligand exposure and bacterial infection in the Indian major carp, mrigal (<italic>Cirrhinus mrigala</italic>)</article-title>
<source>Fish Shellfish Immunol.</source>
<year>2012</year>
<volume>32</volume>
<fpage>121</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="pmid">22085689</pub-id></element-citation></ref><ref id="B22-ijms-15-21935"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Merino</surname><given-names>S.</given-names></name><name><surname>Rubires</surname><given-names>X.</given-names></name><name><surname>Aguilar</surname><given-names>A.</given-names></name><name><surname>Tom&#x000e1;s</surname><given-names>J.M.</given-names></name></person-group>
<article-title>The role of flagella and motility on the adherence and invasion to fish cell lines by <italic>Aeromonas hydrophila</italic> strains serogroup O34</article-title>
<source>FEMS</source>
<year>1997</year>
<volume>151</volume>
<fpage>213</fpage>
<lpage>217</lpage>
</element-citation></ref><ref id="B23-ijms-15-21935"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D.</given-names></name></person-group>
<article-title>Studies on transformation of <italic>Escherichia coli</italic> with plasmids</article-title>
<source>J. Mol. Biol.</source>
<year>1983</year>
<volume>166</volume>
<fpage>557</fpage>
<lpage>580</lpage>
<pub-id pub-id-type="pmid">6345791</pub-id></element-citation></ref><ref id="B24-ijms-15-21935"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canals</surname><given-names>R.</given-names></name><name><surname>Ramirez</surname><given-names>S.</given-names></name><name><surname>Vilches</surname><given-names>S.</given-names></name><name><surname>Horsburgh</surname><given-names>G.</given-names></name><name><surname>Shaw</surname><given-names>J.G.</given-names></name><name><surname>Tom&#x000e1;s</surname><given-names>J.M.</given-names></name><name><surname>Merino</surname><given-names>S.</given-names></name></person-group>
<article-title>Polar flagellum biogenesis in <italic>Aeromonas hydrophila.</italic></article-title>
<source>J. Bacteriol.</source>
<year>2006</year>
<volume>188</volume>
<fpage>542</fpage>
<lpage>555</lpage>
<pub-id pub-id-type="pmid">16385045</pub-id></element-citation></ref><ref id="B25-ijms-15-21935"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carrello</surname><given-names>A.</given-names></name><name><surname>Silburn</surname><given-names>K.A.</given-names></name><name><surname>Budden</surname><given-names>J.R.</given-names></name><name><surname>Chang</surname><given-names>B.J.</given-names></name></person-group>
<article-title>Adhesion of clinical and environmental <italic>Aeromonas</italic> isolates to Hep-2 cells</article-title>
<source>J. Med. Microbiol.</source>
<year>1988</year>
<volume>26</volume>
<fpage>19</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">2897470</pub-id></element-citation></ref><ref id="B26-ijms-15-21935"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pratt</surname><given-names>L.A.</given-names></name><name><surname>Kolter</surname><given-names>R.</given-names></name></person-group>
<article-title>Genetic analysis of Escherichia coli biofilm formation: Role of flagella, motility, chemotaxis and type I pilli</article-title>
<source>Mol. Microbiol.</source>
<year>1998</year>
<volume>30</volume>
<fpage>285</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="pmid">9791174</pub-id></element-citation></ref><ref id="B27-ijms-15-21935"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canals</surname><given-names>R.</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>N.</given-names></name><name><surname>Vilches</surname><given-names>S.</given-names></name><name><surname>Regu&#x000e9;</surname><given-names>M.</given-names></name><name><surname>Merino</surname><given-names>S.</given-names></name><name><surname>Tom&#x000e1;s</surname><given-names>J.M.</given-names></name></person-group>
<article-title>The role of Gne and GalE in the virulence of <italic>Aeromonas hydrophila</italic> serotype O34</article-title>
<source>J. Bacteriol.</source>
<year>2007</year>
<volume>189</volume>
<fpage>540</fpage>
<lpage>550</lpage>
<pub-id pub-id-type="pmid">17098903</pub-id></element-citation></ref><ref id="B28-ijms-15-21935"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jim&#x000e9;nez</surname><given-names>N.</given-names></name><name><surname>Vilches</surname><given-names>S.</given-names></name><name><surname>Lacasta</surname><given-names>A.</given-names></name><name><surname>Regu&#x000e9;</surname><given-names>M.</given-names></name><name><surname>Merino</surname><given-names>S.</given-names></name><name><surname>Tom&#x000e1;s</surname><given-names>J.M.</given-names></name></person-group>
<article-title>A bifunctional enzyme in a single gene catalyzes the incorporation of GlcN into the <italic>Aeromonas</italic> core LPS</article-title>
<source>J. Biol. Chem.</source>
<year>2009</year>
<volume>284</volume>
<fpage>32995</fpage>
<lpage>33005</lpage>
<pub-id pub-id-type="pmid">19805547</pub-id></element-citation></ref><ref id="B29-ijms-15-21935"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Dabbagh</surname><given-names>B.</given-names></name><name><surname>Mengin-Lecreux</surname><given-names>D.</given-names></name><name><surname>Bouhss</surname><given-names>A.</given-names></name></person-group>
<article-title>Purification and characterization of the bacterial UDP-GlcNAC: Undecaprenyl-phosphate GlcNAc-1-phosphate transferase WecA</article-title>
<source>J. Bacteriol.</source>
<year>2008</year>
<volume>190</volume>
<fpage>7141</fpage>
<lpage>7146</lpage>
<pub-id pub-id-type="pmid">18723618</pub-id></element-citation></ref></ref-list></back></article>